AT298667B - Verfahren zur Herstellung von pharmazeutischen Zebereitungen - Google Patents

Verfahren zur Herstellung von pharmazeutischen Zebereitungen

Info

Publication number
AT298667B
AT298667B AT535970A AT535970A AT298667B AT 298667 B AT298667 B AT 298667B AT 535970 A AT535970 A AT 535970A AT 535970 A AT535970 A AT 535970A AT 298667 B AT298667 B AT 298667B
Authority
AT
Austria
Prior art keywords
production
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Application number
AT535970A
Other languages
English (en)
Inventor
Arne Elof Braendstroem
Ulf Krister Junggren
Bo Robert Lamm
Bengt Erik Wilander
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Application granted granted Critical
Publication of AT298667B publication Critical patent/AT298667B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT535970A 1968-06-11 1969-06-11 Verfahren zur Herstellung von pharmazeutischen Zebereitungen AT298667B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2778768A GB1279412A (en) 1968-06-11 1968-06-11 Gastric hydrochloric acid secretion inhibitor, process for the manufacture of such compounds, pharmaceutical composition and a method for the inhibition of gastric hydrochloric acid secretion

Publications (1)

Publication Number Publication Date
AT298667B true AT298667B (de) 1972-05-25

Family

ID=10265313

Family Applications (6)

Application Number Title Priority Date Filing Date
AT535970A AT298667B (de) 1968-06-11 1969-06-11 Verfahren zur Herstellung von pharmazeutischen Zebereitungen
AT535870A AT293430B (de) 1968-06-11 1969-06-11 Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren
AT535570A AT294849B (de) 1968-06-11 1969-06-11 Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren
AT535670A AT293428B (de) 1968-06-11 1969-06-11 Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren
AT552669A AT292012B (de) 1968-06-11 1969-06-11 Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren
AT535770A AT293429B (de) 1968-06-11 1969-06-11 Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren

Family Applications After (5)

Application Number Title Priority Date Filing Date
AT535870A AT293430B (de) 1968-06-11 1969-06-11 Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren
AT535570A AT294849B (de) 1968-06-11 1969-06-11 Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren
AT535670A AT293428B (de) 1968-06-11 1969-06-11 Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren
AT552669A AT292012B (de) 1968-06-11 1969-06-11 Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren
AT535770A AT293429B (de) 1968-06-11 1969-06-11 Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren

Country Status (11)

Country Link
AT (6) AT298667B (de)
BE (1) BE734033A (de)
BR (1) BR6909672D0 (de)
CH (2) CH525193A (de)
DE (1) DE1929416A1 (de)
DK (1) DK126035B (de)
ES (3) ES368207A1 (de)
FR (2) FR2010650B1 (de)
GB (1) GB1279412A (de)
IE (1) IE33149B1 (de)
NL (1) NL6908843A (de)

Also Published As

Publication number Publication date
AT293429B (de) 1971-10-11
DE1929416A1 (de) 1970-07-16
CH539021A (de) 1973-08-31
AT292012B (de) 1971-08-10
AT293428B (de) 1971-10-11
CH525193A (de) 1972-07-15
FR2140246A1 (de) 1973-01-12
GB1279412A (en) 1972-06-28
IE33149L (en) 1969-12-11
ES388702A1 (es) 1973-05-16
ES388703A1 (es) 1974-02-16
IE33149B1 (en) 1974-04-03
FR2010650B1 (de) 1975-01-10
ES368207A1 (es) 1972-04-16
BE734033A (de) 1969-11-17
FR2010650A1 (de) 1970-02-20
BR6909672D0 (pt) 1973-03-13
AT294849B (de) 1971-12-10
DK126035B (da) 1973-06-04
AT293430B (de) 1971-10-11
NL6908843A (de) 1969-12-15

Similar Documents

Publication Publication Date Title
AT287205B (de) Verfahren zur Herstellung von Arzneimittelzubereitungen
CH513786A (de) Verfahren zur Herstellung von Styrylnaphthalin-Derivaten
AT291254B (de) Verfahren zur herstellung von 3-amino-4jod-5-methyllisoxazolen
AT285811B (de) Verfahren zur Herstellung haltbarer Vitaminzubereitungen
AT289084B (de) Verfahren zur Herstellung von Trimethyl-p-benzochinon
AT294064B (de) Verfahren zur Herstellung von 1-Alkyl-2-aminomethylpyrrolidinen
CH500992A (de) Verfahren zur Herstellung von pharmazeutischen Verbindungen
AT282024B (de) Verfahren zur Herstellung von Pigmentzubereitungen
AT305200B (de) Verfahren zur Herstellung von Zubereitungen von Polyadditionsprodukten
AT306228B (de) Verfahren zur Herstellung pharmazeutischer Zubereitungen
CH524609A (de) Verfahren zur Herstellung von 14-Hydroxynormorphinonderivaten
AT318920B (de) Verfahren zur Herstellung stabiler Zubereitungen
CH529132A (de) Verfahren zur Herstellung von 3-Indolylacetamidderivaten
AT292205B (de) Verfahren zur Herstellung von 1-Peracylglykosyl-5-azacytosinen
AT286252B (de) Verfahren zur Herstellung von 3-Aminopropanolen
CH518956A (de) Verfahren zur Herstellung von Isochinuclidin-Derivaten
CH519458A (de) Verfahren zur Herstellung von Isoprenoidchinonderivaten
AT289737B (de) Verfahren zur Herstellung von Sulfatobetainen
CH529835A (de) Verfahren zur Herstellung von Eiweiss
CH513863A (de) Verfahren zur Herstellung von Benzomorphanderivaten
AT296251B (de) Verfahren zur Herstellung von Methylcyclohexenen
AT290555B (de) Verfahren zur Herstellung von Triorganosilanolen
CH534131A (de) Verfahren zur Herstellung von Peptidderivaten
AT288596B (de) Verfahren zur Herstellung pharmazeutischer Präparate
AT297216B (de) Verfahren zur Herstellung von therapeutischen Zubereitungen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee